🔎 Trials Near Me

Akèy › Limfom zòn marenal › Massachusetts › Boston

Etid klinik pou Limfom zòn marenal nan Boston, MA

9 etid pou Limfom zòn marenal ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Ap rekriteFaz 2
  • Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
  • Beth Israel Deaconess Medical Center (Data Collection Only), Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07231952

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Ap rekriteFaz 1/2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05006716

Epco, Zanu, Ritux for R/R FL or MZL

Ap rekriteFaz 2
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06563596

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Mar 16, 2026 · NCT06026319

Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma

Ap rekriteFaz 2
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06510309

Study of SGR-1505 in Mature B-Cell Neoplasms

Ap rekriteFaz 1
  • Beth Israel Deaconess Medical Center, Boston
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Ap rekriteFaz 1/2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT04669171

A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia

Ap rekriteFaz 2
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Dec 5, 2025 · NCT06986174

Etid Limfom zòn marenal nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.